INIFY Stock Overview
Provides cancer diagnostics services in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
INIFY Laboratories AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 5.15 |
| 52 Week High | NOK 13.70 |
| 52 Week Low | NOK 4.00 |
| Beta | 0 |
| 1 Month Change | 10.04% |
| 3 Month Change | -25.90% |
| 1 Year Change | -59.45% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -48.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| INIFY | NO Healthcare | NO Market | |
|---|---|---|---|
| 7D | 13.9% | -2.7% | -2.8% |
| 1Y | -59.4% | 1.9% | -0.8% |
Return vs Industry: INIFY underperformed the Norwegian Healthcare industry which returned 1.9% over the past year.
Return vs Market: INIFY underperformed the Norwegian Market which returned -0.8% over the past year.
Price Volatility
| INIFY volatility | |
|---|---|
| INIFY Average Weekly Movement | 16.3% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in NO Market | 10.9% |
| 10% least volatile stocks in NO Market | 2.6% |
Stable Share Price: INIFY's share price has been volatile over the past 3 months compared to the Norwegian market.
Volatility Over Time: INIFY's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Fredrik Palm | www.inify.com |
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.
INIFY Laboratories AB Fundamentals Summary
| INIFY fundamental statistics | |
|---|---|
| Market cap | NOK 232.97m |
| Earnings (TTM) | NOK 0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs INIFY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INIFY income statement (TTM) | |
|---|---|
| Revenue | NOK 0 |
| Cost of Revenue | NOK 0 |
| Gross Profit | NOK 0 |
| Other Expenses | NOK 0 |
| Earnings | NOK 0 |
Last Reported Earnings
n/a
Next Earnings Date
Feb 26, 2025
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did INIFY perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 04:05 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
INIFY Laboratories AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|